Literature DB >> 18598632

AIDS patient death caused by novel Cryptococcus neoformans x C. gattii hybrid.

Marjan Bovers1, Ferry Hagen, Eiko E Kuramae, Hans L Hoogveld, Françoise Dromer, Guy St-Germain, Teun Boekhout.   

Abstract

Interspecies hybrids of Cryptococcus neoformans and C. gattii have only recently been reported. We describe a novel C. neoformans x C. gattii hybrid strain (serotype AB) that was previously described as C. gattii and that caused a lethal infection in an AIDS patient from Canada.

Entities:  

Mesh:

Year:  2008        PMID: 18598632      PMCID: PMC2600336          DOI: 10.3201/eid1407.080122

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Cryptococcus neoformans and C. gattii are pathogenic yeasts that may cause meningoencephalitis. C. neoformans primarily infects immunocompromised patients and occurs worldwide, whereas C. gattii primarily mainly infects otherwise healthy persons and has been thought to occur in subtropical regions (–). However, the recent outbreak of infection with C. gattii on Vancouver Island, British Columbia, Canada (), expansion of this outbreak to mainland Canada and the Pacific Northwest region of the United States (), and identification of C. gattii isolates in Europe () show that C. gattii can also occur in temperate climates. Molecular techniques can distinguish 7 haploid genotypic groups within C. neoformans and C. gattii (7–9; F. Hagen and T. Boekhout, unpub. data). Recently, 3 serotype BD C. neoformans var. neoformans × C. gattii hybrids were isolated from 2 HIV-negative patients in the Netherlands (). We describe a novel C. neoformans var. grubii serotype A × C. gattii serotype B hybrid that was isolated from an HIV-positive person.

The Study

Strain CBS10496 was isolated from a 31-year-old AIDS patient from Montreal, Quebec, Canada, who had traveled to Mexico ≈15 months before cryptococcosis was diagnosed. The patient died despite extensive antifungal treatment with ketoconazole and amphotericin B (). CBS10496 has been identified as C. gattii serotype B (cited as C. neoformans var. gattii) (). Reference isolates used in this study are listed in the Table.
Table

Cryptococcus spp. strains used in this study*

Strain†Mating type‡/serotypeAFLP/M13 genotype§SourceCountry
CBS9172aAAFLP1/VNISoil sample from garden of patient with neighboring bird coloniesItaly
CBS8710 (H99)αAAFLP1/VNIPatient with Hodgkin diseaseUnited States
CBS1622αBAFLP4/VGITumorFrance
CBS6992αBAFLP4/VGIHumanUnknown
E566aBAFLP4/VGI Eucalyptus camaldulensis Australia
CBS10510 (WM276)αBAFLP4/VGIDebris of E. tereticornisAustralia
CBS10488 (AMC770616)αBaDAFLP8/NAHuman CSFThe Netherlands
CBS10489 (AMC2010404)αBaDAFLP8/NAHuman CSFThe Netherlands
CBS10490 (AMC2011225)αBaDAFLP8/NAHuman CSFThe Netherlands
CBS10496 (LSPQ#308)αA–BAFLP9/NABlood of an HIV-positive patientCanada

*AFLP, amplified fragment length polymorphism; CBS, Fungal Biodiversity Centre; AMC, Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, the Netherlands; NA, not applicable; CSF, cerebrospinal fluid.
†Origin and genetic composition of the strains are indicated.
‡ –, mating type unknown.
§AFLP fingerprint genotype (), followed by corresponding M13 PCR fingerprint genotype ().

*AFLP, amplified fragment length polymorphism; CBS, Fungal Biodiversity Centre; AMC, Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, the Netherlands; NA, not applicable; CSF, cerebrospinal fluid.
†Origin and genetic composition of the strains are indicated.
‡ –, mating type unknown.
§AFLP fingerprint genotype (), followed by corresponding M13 PCR fingerprint genotype (). The ploidy of CBS10496 was determined by using flow cytometry () with the sequenced haploid strains CBS8710 and CBS10510 as references. Nuclei were visualized after staining with 4′,6-diamidino-2-phenylindole (). Coloration of colonies grown on canavanine-glycine-bromthymol blue (CGB) medium () was determined after incubation at 24°C for 6 and 15 days. The serotype of CBS10496 was determined by using the CryptoCheck serotyping kit (Iatron Laboratories, Tokyo, Japan). Ten colonies of CBS10496 were used for DNA extraction (). DNA of these colonies was used for amplified fragment length polymorphism (AFLP) analysis (). The partial sequence of 6 nuclear regions was determined for reference isolates CBS10488–CBS10490, CBS1622, CBS6992, and the putative hybrid isolate CBS10496. Selected nuclear regions were those for internal transcribed spacer (ITS) region, intergenic spacer region, laccase (CNLAC1), 2 RNA polymerase II subunits (RPB1 and RPB2), and translation elongation factor 1α (TEF1α) (,). Mating types and serotype were determined as described (,). DNA content of CBS10496 was compared with that of CBS8710 and CBS10510. The G1 peak of reference strains was located at positions 31.6 (CBS8710) and 31.1 (CBS10510), and the G2 peak was located at positions 65.8 (CBS8710) and 56.4 (CBS10510). The G1 peak of CBS10496 was located at position 57.5, and the G2 peak was located at position 115.7. Thus, the G1 peak of CBS10496 coincided with the G2 peak of the haploid strains (Figure 1, panel A), which indicates that CBS10496 has ≈2× more DNA than haploid strains. We concluded that CBS10496 is diploid or aneuploid. Staining with 4′,6-diamidino-2-phenylindole showed that cells of CBS10496 were monokaryotic (Figure 1, panel B).
Figure 1

A) Determination of ploidy of the novel Cryptococcus neoformans × C. gattii serotype AB hybrid isolate CBS10496 by flow cytometry. The first peak corresponds to the G1 phase; the second peak corresponds to the G2 phase. Haploid reference strain CBS10510 is shown by the red line; CBS10496 is shown by the black line. The G1 peak of CBS10496 coincided with the G2 peak of strain CBS10510, which indicated that strain CBS10496 has approximately twice the amount of DNA than CBS10510. B) Nuclear staining of isolate CBS10496 with 4′,6-diamidino-2-phenylindole, showing that cells are monokaryotic. Scale bar = 10 μm.

A) Determination of ploidy of the novel Cryptococcus neoformans × C. gattii serotype AB hybrid isolate CBS10496 by flow cytometry. The first peak corresponds to the G1 phase; the second peak corresponds to the G2 phase. Haploid reference strain CBS10510 is shown by the red line; CBS10496 is shown by the black line. The G1 peak of CBS10496 coincided with the G2 peak of strain CBS10510, which indicated that strain CBS10496 has approximately twice the amount of DNA than CBS10510. B) Nuclear staining of isolate CBS10496 with 4′,6-diamidino-2-phenylindole, showing that cells are monokaryotic. Scale bar = 10 μm. Reaction of CBS10496 on CGB medium was negative, which corresponds to C. neoformans (). The CryptoCheck serotyping kit serum factors 5 (corresponding to serotype B) and 7 (corresponding to serotype A) agglutinated, which indicated that CBS10496 is a serotype AB strain. The AFLP fingerprint obtained by analysis of colonies of CBS10496 did not match any of the previously defined AFLP genotypes. The fingerprint of CBS10496 was compared with AFLP fingerprints of reference strains CBS8710 and CBS9172, which are AFLP1/VNI, and E566 and CBS10510, which are AFLP4/VGI. The AFLP fingerprint of CBS10496 contained fragments characteristic of AFLP1/VNI and AFLP4/VGI (Figure 2), which indicated that genetic material from these 2 genotypes was present in this isolate.
Figure 2

Amplified fragment length polymorphism (AFLP) fingerprint of 3 colonies of the novel Cryptococcus neoformans × C. gattii hybrid serotype AB isolate CBS10496 and 4 reference strains. CBS9172 and CBS8710 are C. neoformans var. grubii (AFLP1/VNI) strains; E566 and CBS10510 are C. gattii (AFLP4/VGI) strains. Rectangles indicate AFLP fragments characteristic for AFLP1/VNI or AFLP4/VGI and present in isolate CBS10496.

Amplified fragment length polymorphism (AFLP) fingerprint of 3 colonies of the novel Cryptococcus neoformans × C. gattii hybrid serotype AB isolate CBS10496 and 4 reference strains. CBS9172 and CBS8710 are C. neoformans var. grubii (AFLP1/VNI) strains; E566 and CBS10510 are C. gattii (AFLP4/VGI) strains. Rectangles indicate AFLP fragments characteristic for AFLP1/VNI or AFLP4/VGI and present in isolate CBS10496. Two alleles representing AFLP1/VNI and AFLP4/VGI were found when fragments of RPB1, RPB2, CNLAC1, and intergenic spacer region of CBS10496 were cloned and sequenced. However, after 30 clones were sequenced, only 1 allele was obtained for TEF1α, i.e., AFLP4/VGI, and ITS, i.e., AFLP1/VNI. Our results indicate that genetic material from AFLP1/VNI and AFLP4/VGI was present in CBS10496, although only 1 allele was obtained for TEF1α and ITS. All sequences were submitted to GenBank (accession nos. DQ286656–DQ286676 and EF102027–EF102072). Amplification of CBS10496 in a PCR with the MATα and the MATα serotype A–specific primer pair resulted in an amplicon. When MATa and the MATa serotype A–specific PCRs were conducted, no amplicon was obtained. These findings indicate that CBS10496 has a MATα serotype A background. All reference strains yielded amplicons with the expected primer pairs. In addition, CBS10510, a MATα serotype B strain, was amplified with the MATα specific primer pair, and E566, a MATa serotype B strain, yielded an amplicon with the MATa-specific PCR. These results indicate that a C. gattii and a MATα serotype A background are present in CBS10496. Because the mating type of the C. gattii background within CBS10496 was unknown, 30 MATα clones of CBS10496 were sequenced to determine whether a MATα serotype B allele could be identified. However, all clones were MATα serotype A; no MATα serotype B clones were found.

Conclusions

Our results indicated that CBS10496 is a monokaryotic, diploid, or aneuploid strain with the novel AB serotype. AFLP and sequence analysis showed that the isolate contained fragments of C. neoformans var. grubii (AFLP1/VNI) and C. gattii (AFLP4/VGI). We conclude that this isolate is a novel aneuploid hybrid of C. neoformans var. grubii (serotype A, AFLP1/VNI) and C. gattii (serotype B, AFLP4/VGI). CBS10496 had been identified as C. gattii on the basis of a weak positive reaction on CGB medium (). Our results indicated that CBS10496 was negative on CGB medium. Although a negative response on CGB medium has been shown for other C. neoformans × C. gattii hybrids (,), weak and delayed positive reactions on CGB medium may occur in C. neoformans × C. gattii hybrid isolates (,). CBS10496 was previously identified as a serotype B strain (). Inconsistent serotyping results have been reported for other hybrids (,) and may result from differences in specificity and potency among different batches of factor serum. All C. neoformans × C. gattii hybrids discovered have originated from clinical sources (13; F. Hagen and T. Boekhout, unpub. data). We expected that CBS10496 would have 2 mating-type loci. However, only a serotype A MATα background was observed. Although an amplicon was obtained with C. gattii–specific mating-type primers, the C. gattii background could not be linked to a mating type. We hypothesize that the serotype AB C. neoformans × C. gattii hybrid CBS10496 was formed by mating of a MATa serotype B strain with a MATα serotype A strain and subsequent loss of the MATa serotype B allele. Detection of single ITS and TEF1α alleles in CBS10496 further supports our findings because it indicates that other alleles were also lost. Loss of genetic material has been observed in other hybrids, such as serotype AD and BD hybrids (), and seems to be a normal process in cryptococcal hybrids. Our results show that the C. gattii parent of the serotype AB hybrid belongs to the AFLP4/VGI genotype, as was the case for serotype BD hybrids (). The C. gattii parental sequence of all known serotype BD C. neoformans × C. gattii hybrid isolates was identical to sequences of AFLP4/VGI strains CBS1622 and CBS6992 in all regions studied (). Detection of 1 specific C. gattii–AFLP4/VGI subgroup in all isolated C. neoformans × C. gattii hybrids may indicate that this subgroup preferentially forms interspecies hybrids.
  15 in total

1.  Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil.

Authors:  M T Barreto de Oliveira; T Boekhout; B Theelen; F Hagen; F A Baroni; M S Lazera; K B Lengeler; J Heitman; I N G Rivera; C R Paula
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD.

Authors:  M A Viviani; H Wen; A Roverselli; R Caldarelli-Stefano; M Cogliati; P Ferrante; A M Tortorano
Journal:  J Med Vet Mycol       Date:  1997 Sep-Oct

3.  Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Marjan Bovers; Ferry Hagen; Eiko E Kuramae; Mara R Diaz; Lodewijk Spanjaard; Françoise Dromer; Hans L Hoogveld; Teun Boekhout
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

Review 4.  Do major species concepts support one, two or more species within Cryptococcus neoformans?

Authors:  Kyung J Kwon-Chung; Ashok Varma
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

5.  Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.

Authors:  Maria Anna Viviani; Massimo Cogliati; Maria Carmela Esposto; Karin Lemmer; Kathrin Tintelnot; Maria Francisca Colom Valiente; Danielle Swinne; Aristea Velegraki; Rosa Velho
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

6.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

Authors:  S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

7.  Epidemiologic differences between the two varieties of Cryptococcus neoformans.

Authors:  K J Kwon-Chung; J E Bennett
Journal:  Am J Epidemiol       Date:  1984-07       Impact factor: 4.897

8.  Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA.

Authors:  Laura MacDougall; Sarah E Kidd; Eleni Galanis; Sunny Mak; Mira J Leslie; Paul R Cieslak; James W Kronstad; Muhammad G Morshed; Karen H Bartlett
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Clinical and host differences between infections with the two varieties of Cryptococcus neoformans.

Authors:  B Speed; D Dunt
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

10.  Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing.

Authors:  M Bovers; F Hagen; E E Kuramae; T Boekhout
Journal:  Fungal Genet Biol       Date:  2007-12-23       Impact factor: 3.495

View more
  44 in total

1.  High-resolution melting analysis for identification of the Cryptococcus neoformans-Cryptococcus gattii complex.

Authors:  Sara Gago; Óscar Zaragoza; Isabel Cuesta; Juan L Rodríguez-Tudela; Manuel Cuenca-Estrella; María J Buitrago
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

Review 2.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.

Authors:  Ferry Hagen; María-Teresa Illnait-Zaragozí; Jacques F Meis; William H M Chew; Ilse Curfs-Breuker; Johan W Mouton; Andy I M Hoepelman; Lodewijk Spanjaard; Paul E Verweij; Greetje A Kampinga; Ed J Kuijper; Teun Boekhout; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

4.  Development of a singleplex PCR assay for rapid identification and differentiation of Cryptococcus neoformans var. grubii, Cryptococcus neoformans var. neoformans, Cryptococcus gattii, and hybrids.

Authors:  Xiaobo Feng; Xiaohua Fu; Bo Ling; Lei Wang; Wanqing Liao; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

5.  Identification and molecular analysis of pathogenic yeasts in droppings of domestic pigeons in Beijing, China.

Authors:  Yuan Wu; Peng-Cheng Du; Wen-Ge Li; Jin-Xing Lu
Journal:  Mycopathologia       Date:  2012-04-03       Impact factor: 2.574

6.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

7.  Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America.

Authors:  Ashwin Dixit; Scott F Carroll; Salman T Qureshi
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-25

8.  C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi.

Authors:  Marein A W P de Jong; Lianne E M Vriend; Bart Theelen; Maureen E Taylor; Donna Fluitsma; Teun Boekhout; Teunis B H Geijtenbeek
Journal:  Mol Immunol       Date:  2010-01-25       Impact factor: 4.407

9.  Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages.

Authors:  Maria-Teresa Illnait-Zaragozi; Gerardo F Martínez-Machín; Carlos M Fernández-Andreu; Teun Boekhout; Jacques F Meis; Corné H W Klaassen
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

10.  "Much Madness is Divinest Sense".

Authors:  Polyxeni Potter
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.